Tissue-specific Activation
Tissue-Specific Activation is a bioprecursor prodrug strategy that belongs to the class of site-selective drug delivery mechanisms, distinguished by its reliance on enzymatic or physiological conditions unique to particular tissues to selectively convert an inactive prodrug into its active pharmacological form.
102
Publications
9.8K
Citations
559
Authors
202
Institutions
Publications per year
2017–2026
19
Variants
Tissue-selective Activation
102
Sequence requirements for myosin gene expression and regulation in Caenorhabditis elegans.
Peter G. Okkema, Susan White Harrison, V Plunger et al. · Genetics · 1993 · 438 citations · Full text
Ulrike Hartmann, Martin Sagasser, Mehrtens Frank et al. · Plant Molecular Biology · 2005 · 438 citations · Full text
1–5 of 102
559
2
h-index
2
h-index
2
h-index
Whitehead Institute for Biomedical Research, United States
2 publications · 113 citations
2
h-index
2
h-index
1–5 of 559
202
Harvard University
Cambridge, United States
4 h-index
7 publications
506 citations

University Hospital Heidelberg
Heidelberg, Germany
3 h-index
10 publications
540 citations
Inserm
Paris, France
3 h-index
8 publications
763 citations
Heidelberg University
Heidelberg, Germany
3 h-index
11 publications
607 citations

Howard Hughes Medical Institute
Chevy Chase, United States
3 h-index
8 publications
787 citations
Medizinische Hochschule Hannover
Hanover, Germany
3 h-index
4 publications
570 citations

Brookhaven National Laboratory
Upton, United States
2 h-index
4 publications
124 citations
Michigan Medicine
Ann Arbor, United States
2 h-index
4 publications
76 citations
1–8 of 202
MCB · 8 publications · 1K citations
8
h-index
JBC · 7 publications · 749 citations
7
h-index
Repository · 6 publications · 150 citations
6
h-index
5 publications · 1.1K citations
5
h-index
4 publications · 176 citations
4
h-index
1–5